Yes, group B streptococcus (GBS) can cause urinary tract infections. It’s far less common than the usual culprit, E. coli, but GBS was found in about 1.1% of consecutive urine samples in one large study of adults. The infection matters most during pregnancy, where GBS accounts for roughly 10% of kidney infections and complicates up to 7% of pregnancies overall.
Who Gets GBS Urinary Infections
GBS lives naturally in the gastrointestinal and genital tracts of many adults without causing problems. It becomes an issue in the urinary tract primarily for three groups: pregnant women, older adults, and people with weakened immune systems.
Diabetes is the single biggest risk factor outside of pregnancy. A U.S. survey spanning 1990 to 2007 found that 88% of people with invasive GBS infections had at least one underlying medical condition, and diabetes topped the list. A later study covering 2008 to 2016 confirmed the pattern, with obesity and diabetes remaining the leading risk factors. The connection appears to be biological: excess glucose in the body helps GBS stick to tissue, form protective biofilms, and activate genes that make the bacteria more resilient. When researchers grew GBS in human urine supplemented with high glucose levels, the bacteria ramped up expression of genes tied to virulence and survival against the immune system’s defenses.
Symptoms and Diagnosis
A GBS urinary infection feels much like any other UTI. You can expect the usual burning with urination, frequent urges to go, cloudy or strong-smelling urine, and pelvic discomfort. If the infection reaches the kidneys, fever, flank pain, nausea, and chills can follow. There’s nothing about the symptoms alone that would tip you or your doctor off that GBS is the cause rather than E. coli. That distinction comes from a urine culture.
The threshold for diagnosing a GBS urinary infection is lower than for most other bacteria. While a standard UTI diagnosis typically requires at least 100,000 colony-forming units per milliliter (CFU/mL) of a single pathogen, GBS triggers treatment at just 10,000 CFU/mL. This lower bar exists because GBS in the urine signals heavy colonization elsewhere in the body, which carries its own risks, particularly during pregnancy.
Why GBS in Urine Matters During Pregnancy
GBS shows up in the urine of 2% to 7% of pregnant women. Even when it causes no symptoms at all, its presence is treated seriously. The CDC considers GBS in a pregnant woman’s urine a marker for heavy colonization in the genital and rectal areas, which creates a direct risk of passing the bacteria to the baby during delivery.
The concern is early-onset GBS disease in the newborn, a serious infection that can cause sepsis, pneumonia, or meningitis in the first week of life. Research has found that even low colony counts of GBS in maternal urine are associated with elevated risk to the baby compared to mothers without GBS bacteriuria. One study from Utah documented this increased risk even at bacterial counts below the traditional 100,000 CFU/mL cutoff.
Because of this, any pregnant woman with GBS found in her urine at any point during the pregnancy is flagged for intravenous antibiotics during labor. She does not need the routine late-pregnancy GBS screening swab, because the urine finding already confirms significant colonization. Both symptomatic and asymptomatic GBS urinary infections during pregnancy are treated: the UTI itself gets a course of oral antibiotics, and then antibiotics are given again through an IV once labor begins to protect the baby.
GBS Screening in Late Pregnancy
All pregnant women are screened for GBS colonization between 36 and 37 weeks of gestation using a vaginal and rectal swab. This timing gives a five-week window during which the culture results remain valid, covering births up to at least 41 weeks. Women who already have GBS in their urine or who previously had a baby with GBS disease skip this screening, since they’re already scheduled for labor antibiotics regardless.
If a woman’s GBS status is unknown when labor starts, antibiotics are recommended when additional risk factors are present: preterm labor, water broken for 18 hours or more, or a fever of 100.4°F or higher during labor.
Treatment for GBS Urinary Infections
Penicillin-based antibiotics remain the first choice for GBS infections. The bacteria are still remarkably susceptible: globally, only about 0.7% of GBS isolates show resistance to penicillin, and resistance to ampicillin sits at just 1%. This makes GBS one of the more reliably treatable causes of UTI.
For people allergic to penicillin, the picture gets more complicated. Clindamycin, once a common alternative, now faces a 20% global resistance rate that climbed to 32% between 2021 and 2024. Erythromycin resistance has followed a similar upward trend. Because of this, doctors typically test the specific bacteria for susceptibility before prescribing alternatives. For serious penicillin allergies, options include first-generation cephalosporins (for those at low risk of a severe allergic reaction) or vancomycin, which still has resistance rates below 1%.
Treatment length depends on where the infection has settled. A straightforward bladder infection is treated with a shorter course, while a kidney infection generally calls for around ten days of antibiotics.
Asymptomatic GBS in Urine: When It Needs Treatment
Outside of pregnancy, finding GBS in the urine of someone with no symptoms does not automatically require antibiotics. Screening for and treating asymptomatic bacteriuria is generally not recommended in healthy, non-pregnant adults. Treating bacteria that aren’t causing problems contributes to antibiotic resistance without clear benefit.
Pregnancy is the major exception. Because asymptomatic GBS bacteriuria signals heavy colonization and raises the risk of newborn infection, it’s treated whenever it’s found, regardless of trimester. The urine infection itself gets antibiotics, and the finding triggers the plan for IV antibiotics during delivery. This two-step approach, treating the UTI now and protecting the baby later, is standard practice across major obstetric guidelines.